New Zealand markets close in 4 hours 59 minutes
  • NZX 50

    11,159.66
    -20.35 (-0.18%)
     
  • NZD/USD

    0.5749
    +0.0020 (+0.36%)
     
  • NZD/EUR

    0.5809
    +0.0078 (+1.36%)
     
  • ALL ORDS

    7,030.90
    +125.60 (+1.82%)
     
  • ASX 200

    6,815.70
    +116.40 (+1.74%)
     
  • OIL

    88.08
    +0.32 (+0.36%)
     
  • GOLD

    1,724.90
    +4.10 (+0.24%)
     
  • NASDAQ

    11,573.18
    -9.36 (-0.08%)
     
  • FTSE

    7,052.62
    -33.84 (-0.48%)
     
  • Dow Jones

    30,273.87
    -42.45 (-0.14%)
     
  • DAX

    12,517.18
    -153.30 (-1.21%)
     
  • Hang Seng

    18,087.97
    +1,008.46 (+5.90%)
     
  • NIKKEI 225

    27,120.53
    +128.32 (+0.48%)
     
  • NZD/JPY

    83.0350
    +0.4720 (+0.57%)
     

West Pharmaceutical Services (WST) is a Top-Ranked Growth Stock: Should You Buy?

·2-min read

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors.

While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks based on value, growth, and/or momentum characteristics.

Why This 1 Growth Stock Should Be On Your Watchlist

Growth investors build their portfolios around companies that are financially strong and have a bright future, and the Growth Style Score helps take projected and historical earnings, sales, and cash flow into account to uncover stocks that will see long-term, sustainable growth.

West Pharmaceutical Services (WST)

West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments – Proprietary Products and Contract-Manufactured Products.

WST boasts a Growth Style Score of B and VGM Score of B, and holds a Zacks Rank #3 (Hold) rating. Its bottom-line is projected to rise 8.7% year-over-year for 2022, while Wall Street anticipates its top line to improve by 8%.

Four analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.05 to $9.33 per share for 2022. WST boasts an average earnings surprise of 16.6%.

Looking at cash flow, West Pharmaceutical Services is expected to report cash flow growth of 65.6% this year; WST has generated cash flow growth of 25.1% over the past three to five years.

WST should be on investors' short lists because of its impressive growth fundamentals, a good Zacks Rank, and strong Growth and VGM Style Scores.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
To read this article on Zacks.com click here.